BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006;30:643-653. [PMID: 16680581 DOI: 10.1007/s00268-006-0360-y] [Cited by in Crossref: 106] [Cited by in F6Publishing: 80] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Lewis RB, Lattin GE Jr, Paal E. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics. 2010;30:1445-1464. [PMID: 21071369 DOI: 10.1148/rg.306105523] [Cited by in Crossref: 152] [Cited by in F6Publishing: 113] [Article Influence: 15.2] [Reference Citation Analysis]
2 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M. Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surg Today. 2013;43:229-236. [PMID: 23076685 DOI: 10.1007/s00595-012-0376-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Nell S, Borel Rinkes IHM, Verkooijen HM, Bonsing BA, van Eijck CH, van Goor H, de Kleine RHJ, Kazemier G, Nieveen van Dijkum EJ, Dejong CHC, Valk GD, Vriens MR; DMSG. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors. Ann Surg 2018;267:352-6. [PMID: 27811505 DOI: 10.1097/SLA.0000000000002050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
4 Imamura M, Komoto I, Ota S, Hiratsuka T, Kosugi S, Doi R, Awane M, Inoue N. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol 2011; 17(10): 1343-1353 [PMID: 21455335 DOI: 10.3748/wjg.v17.i10.1343] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
5 Raef H, Zou M, Baitei EY, Al-Rijjal RA, Kaya N, Al-Hamed M, Monies D, Abu-Dheim NN, Al-Hindi H, Al-Ghamdi MH, Meyer BF, Shi Y. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype. Clin Endocrinol (Oxf) 2011;75:791-800. [PMID: 21627674 DOI: 10.1111/j.1365-2265.2011.04134.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
6 Thakker RV. Multiple Endocrine Neoplasia Type 1. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 2566-2593.e9. [DOI: 10.1016/b978-0-323-18907-1.00148-7] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lopez CL, Waldmann J, Fendrich V, Langer P, Kann PH, Bartsch DK. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg 2011;396:1187-96. [PMID: 21805182 DOI: 10.1007/s00423-011-0828-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Ratnayake CBB, Loveday BP, Windsor JA, Lawrence B, Pandanaboyana S. Patient characteristics and clinical outcomes following initial surgical intervention for MEN1 associated pancreatic neuroendocrine tumours: A systematic review and exploratory meta-analysis of the literature. Pancreatology 2019;19:462-71. [DOI: 10.1016/j.pan.2019.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Bax KN, van der Zee DC. The laparoscopic approach toward hyperinsulinism in children. Semin Pediatr Surg 2007;16:245-51. [PMID: 17933666 DOI: 10.1053/j.sempedsurg.2007.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
11 Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM. Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer. 2012;19:R163-R185. [PMID: 22645227 DOI: 10.1530/erc-12-0024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 45] [Article Influence: 9.1] [Reference Citation Analysis]
12 Liu JB, Baker MS. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Clin North Am. 2016;96:1447-1468. [PMID: 27865287 DOI: 10.1016/j.suc.2016.07.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
13 Libé R, Chanson P. [Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment]. Ann Endocrinol (Paris) 2007;68 Suppl 1:1-8. [PMID: 17961653 DOI: 10.1016/s0003-4266(07)80002-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML;  Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990-3011. [PMID: 22723327 DOI: 10.1210/jc.2012-1230] [Cited by in Crossref: 695] [Cited by in F6Publishing: 505] [Article Influence: 77.2] [Reference Citation Analysis]
15 Mortellaro VE, Hochwald SN, Mcguigan JE, Copeland EM, Vogel SB, Grobmyer SR. Long-Term Results of a Selective Surgical Approach to Management of Zollinger-Ellison Syndrome in Patients with MEN-1. The American Surgeon 2009;75:730-3. [DOI: 10.1177/000313480907500818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Soczomski P, Jurecka-Lubieniecka B, Krzywon A, Cortez AJ, Zgliczynski S, Rogozik N, Oczko-Wojciechowska M, Pawlaczek A, Bednarczuk T, Jarzab B. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations. Front Endocrinol (Lausanne) 2021;12:681013. [PMID: 34122352 DOI: 10.3389/fendo.2021.681013] [Reference Citation Analysis]
17 Mele C, Mencarelli M, Caputo M, Mai S, Pagano L, Aimaretti G, Scacchi M, Falchetti A, Marzullo P. Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations. Front Endocrinol (Lausanne) 2020;11:591501. [PMID: 33312161 DOI: 10.3389/fendo.2020.591501] [Reference Citation Analysis]
18 Grobmyer SR, Hochwald SN. Reoperative Surgery for the Zollinger-Ellison Syndrome. Advances in Surgery 2010;44:327-46. [DOI: 10.1016/j.yasu.2010.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Thakker RV. Multiple Endocrine Neoplasia Type 1. Endocrinology. Elsevier; 2010. pp. 2719-41. [DOI: 10.1016/b978-1-4160-5583-9.00150-7] [Cited by in Crossref: 15] [Article Influence: 1.4] [Reference Citation Analysis]
20 Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 2008;113:1807-43. [PMID: 18798544 DOI: 10.1002/cncr.23648] [Cited by in Crossref: 286] [Cited by in F6Publishing: 225] [Article Influence: 22.0] [Reference Citation Analysis]
21 Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'connor JM, Salazar R, Taal BG, Vullierme MP, O'toole D. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors. Neuroendocrinology 2012;95:120-34. [DOI: 10.1159/000335587] [Cited by in Crossref: 326] [Cited by in F6Publishing: 255] [Article Influence: 36.2] [Reference Citation Analysis]
22 Erdas E, Aste N, Pilloni L, Nicolosi A, Licheri S, Cappai A, Mastinu M, Cetani F, Pardi E, Mariotti S, Pomata M. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association? BMC Cancer 2012;12:614. [PMID: 23259638 DOI: 10.1186/1471-2407-12-614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Gauger PG, Doherty GM, Broome JT, Miller BS, Thompson NW. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery 2009;146:801-8. [DOI: 10.1016/j.surg.2009.06.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
24 Finkelstein P, Sharma R, Picado O, Gadde R, Stuart H, Ripat C, Livingstone AS, Sleeman D, Merchant N, Yakoub D. Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection. J Gastrointest Surg. 2017;21:855-866. [PMID: 28255853 DOI: 10.1007/s11605-017-3365-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
25 Challis BG, Casey RT, Grossman A, Newell-Price J, Newey P, Thakker RV. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1? Clin Endocrinol (Oxf) 2019;91:708-15. [PMID: 31505044 DOI: 10.1111/cen.14094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Pieterman CRC, Conemans EB, Dreijerink KMA, de Laat JM, Timmers HTM, Vriens MR, Valk GD. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. Endocrine-Related Cancer 2014;21:R121-42. [DOI: 10.1530/erc-13-0482] [Cited by in Crossref: 51] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
27 Norton JA, Krampitz G, Jensen RT. Multiple Endocrine Neoplasia: Genetics and Clinical Management. Surg Oncol Clin N Am 2015;24:795-832. [PMID: 26363542 DOI: 10.1016/j.soc.2015.06.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
28 Tsolakis A, Kanakis G. Pancreatic Neuroendocrine Tumors. In: Islam MS, editor. Islets of Langerhans, 2. ed.. Dordrecht: Springer Netherlands; 2013. pp. 1-29. [DOI: 10.1007/978-94-007-6884-0_50-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Rich TA, Liu M, Etzel CJ, Bannon SA, Mork ME, Ready K, Saraiya DS, Grubbs EG, Perrier ND, Lu KH. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer. 2014;13:291-299. [PMID: 24072553 DOI: 10.1007/s10689-013-9685-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
30 Tonelli F, Giudici F, Giusti F, Brandi ML. Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers (Basel) 2012;4:504-22. [PMID: 24213321 DOI: 10.3390/cancers4020504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
31 Sadowski SM, Triponez F. Management of pancreatic neuroendocrine tumors in patients with MEN 1. Gland Surg 2015;4:63-8. [PMID: 25713781 DOI: 10.3978/j.issn.2227-684X.2014.12.01] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
32 Camera L, Paoletta S, Mollica C, Milone F, Napolitano V, De Luca L, Faggiano A, Colao A, Salvatore M. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound. Radiol Med. 2011;116:595-606. [PMID: 21286942 DOI: 10.1007/s11547-011-0636-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
33 Kemm MH, Manly CD, Hoang TD, Mai VQ, Shakir MKM. Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature. Case Rep Gastrointest Med. 2019;2019:9462942. [PMID: 31183223 DOI: 10.1155/2019/9462942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Nuñez JE, Donadio M, Filho DR, Rego JF, Barros M, Formiga MN, Lopez R, Riechelmann R. The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors. J Gastrointest Oncol 2019;10:645-51. [PMID: 31392045 DOI: 10.21037/jgo.2019.01.33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
35 Feldmann G, Bisht S, Schütte U, Haarmann J, Brossart P. Everolimus for the treatment of pancreatic neuroendocrine tumors. Expert Opinion on Pharmacotherapy 2012;13:2073-84. [DOI: 10.1517/14656566.2012.713348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
36 Clancy TE. Surgical Management of Pancreatic Neuroendocrine Tumors. Hematol Oncol Clin North Am 2016;30:103-18. [PMID: 26614371 DOI: 10.1016/j.hoc.2015.09.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
37 Thakker RV. Familial and Hereditary Forms of Primary Hyperparathyroidism. The Parathyroids. Elsevier; 2015. pp. 341-63. [DOI: 10.1016/b978-0-12-397166-1.00023-0] [Cited by in Crossref: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Minter RM, Simeone DM. Contemporary Management of Nonfunctioning Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 2012;16:435-46. [DOI: 10.1007/s11605-011-1693-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
39 Pea A, Hruban RH, Wood LD. Genetics of pancreatic neuroendocrine tumors: implications for the clinic. Expert Rev Gastroenterol Hepatol. 2015;9:1407-1419. [PMID: 26413978 DOI: 10.1586/17474124.2015.1092383] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
40 Weiss DE, Vogel H, Lopes MBS, Chang SD, Katznelson L. Ectopic Acromegaly due to A Pancreatic Neuroendocrine Tumor Producing Growth Hormone-Releasing Hormone. Endocrine Practice 2011;17:79-84. [DOI: 10.4158/ep10165.cr] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
41 You YN, Thompson GB, Young WF Jr, Larson D, Farley DR, Richards M, Grant CS. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery 2007;142:829-36; discussion 836.e1. [PMID: 18063064 DOI: 10.1016/j.surg.2007.09.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
42 Jensen RT, Norton JA. Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy. Pancreas. 2017;46:589-594. [PMID: 28426491 DOI: 10.1097/mpa.0000000000000825] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
43 Pieterman CRC, Vriens MR, Dreijerink KMA, van der Luijt RB, Valk GD. Care for patients with multiple endocrine neoplasia type 1: the current evidence base. Familial Cancer 2011;10:157-71. [DOI: 10.1007/s10689-010-9398-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
44 Kamilaris CDC, Stratakis CA. Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.Front Endocrinol (Lausanne). 2019;10:339. [PMID: 31263451 DOI: 10.3389/fendo.2019.00339] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 20.5] [Reference Citation Analysis]
45 Li Y, Simonds WF. Endocrine neoplasms in familial syndromes of hyperparathyroidism. Endocr Relat Cancer 2016;23:R229-47. [PMID: 27207564 DOI: 10.1530/ERC-16-0059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
46 Cavalli T, Giudici F, Santi R, Nesi G, Brandi ML, Tonelli F. Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome. Fam Cancer 2016;15:645-9. [PMID: 27071757 DOI: 10.1007/s10689-016-9906-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
47 Zhou G, Wei Y, Chen X, Jiang X, Gu W, Li X, Peng C, Ning G, Li H. Multiple endocrine neoplasia type 1 simultaneous with various types of enteropancreatic endocrine tumors: one case report: lessons learned. Pancreas. 2010;39:680-683. [PMID: 20562579 DOI: 10.1097/MPA.0b013e3181d36341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Tonelli F, Giudici F, Fratini G, Brandi ML. Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocr Pract. 2011;17 Suppl 3:33-40. [PMID: 21550956 DOI: 10.4158/ep10376.ra] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
49 Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2019;14:54. [PMID: 30795813 DOI: 10.1186/s13023-019-1034-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Manoharan J, Waldmann J, Langer P, Bartsch DK. Inherited Pancreatic Endocrine Tumors. In: Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW, editors. Pancreatic Cancer. New York: Springer; 2017. pp. 1-25. [DOI: 10.1007/978-1-4939-6631-8_25-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL, Pappas SG. The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery 2008;144:695-701; discussion 701-2. [PMID: 18847656 DOI: 10.1016/j.surg.2008.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
52 Lairmore TC, Chen H. Role of menin in neuroendocrine tumorigenesis. Adv Exp Med Biol 2009;668:87-95. [PMID: 20175456 DOI: 10.1007/978-1-4419-1664-8_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Doi R. Determinants of surgical resection for pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:610-617. [PMID: 25773163 DOI: 10.1002/jhbp.224] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
54 Piecha G, Chudek J, Więcek A. Multiple endocrine neoplasia type 1. European Journal of Internal Medicine 2008;19:99-103. [DOI: 10.1016/j.ejim.2007.08.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
55 Akerström G, Stålberg P, Hellman P. Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1. Clinics (Sao Paulo) 2012;67 Suppl 1:173-8. [PMID: 22584725 DOI: 10.6061/clinics/2012(sup01)29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol. 2007;19:30-35. [PMID: 17133109 DOI: 10.1097/cco.0b013e328011a236] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
57 Donegan D, Singh Ospina N, Rodriguez-Gutierrez R, Al-Hilli Z, Thompson GB, Clarke BL, Young WF Jr. Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours. Clin Endocrinol (Oxf) 2017;86:199-206. [PMID: 27770475 DOI: 10.1111/cen.13264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
58 Norton JA, Foster DS, Ito T, Jensen RT. Gastrinomas: Medical or Surgical Treatment. Endocrinol Metab Clin North Am. 2018;47:577-601. [PMID: 30098717 DOI: 10.1016/j.ecl.2018.04.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
59 Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95:627-35. [PMID: 18306152 DOI: 10.1002/bjs.6051] [Cited by in Crossref: 187] [Cited by in F6Publishing: 163] [Article Influence: 14.4] [Reference Citation Analysis]
60 van Beek DJ, Nell S, Verkooijen HM, Borel Rinkes IHM, Valk GD, Vriens MR; DutchMEN Study Group (DMSG)., International MEN1 Insulinoma Study Group., DutchMEN Surgery Study Group. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters. Surgery 2021;169:963-73. [PMID: 33220975 DOI: 10.1016/j.surg.2020.09.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Butte JM, Montero PH, Solar A, Torres J, Olmos PR, Goñi I, Quintana JC, Martínez J, Llanos O. Cervical metastases of glucagonoma in a patient with multiple endocrine neoplasia type 1: Report of a case. Surg Today 2008;38:1137-43. [DOI: 10.1007/s00595-008-3763-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Muniraj T, Vignesh S, Shetty S, Thiruvengadam S, Aslanian HR. Pancreatic neuroendocrine tumors. Disease-a-Month 2013;59:5-19. [DOI: 10.1016/j.disamonth.2012.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
63 Davila A, Menias CO, Alhalabi K, Lall C, Pickhardt PJ, Lubner M, Elsayes KM. Multiple Endocrine Neoplasia: Spectrum of Abdominal Manifestations. AJR Am J Roentgenol 2020;215:885-95. [PMID: 32755185 DOI: 10.2214/AJR.19.22542] [Reference Citation Analysis]
64 Newey PJ, Jeyabalan J, Walls GV, Christie PT, Gleeson FV, Gould S, Johnson PRV, Phillips RR, Ryan FJ, Shine B, Bowl MR, Thakker RV. Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors. The Journal of Clinical Endocrinology & Metabolism 2009;94:3640-6. [DOI: 10.1210/jc.2009-0564] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
65 Nell S, Verkooijen HM, Pieterman CRC, de Herder WW, Hermus AR, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IHM, Vriens MR, Valk GD. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group. Ann Surg 2018;267:1155-60. [PMID: 28257328 DOI: 10.1097/SLA.0000000000002183] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
66 Christakis I, Qiu W, Hyde SM, Cote GJ, Grubbs EG, Perrier ND, Lee JE. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution. Surgery 2018;163:212-7. [DOI: 10.1016/j.surg.2017.04.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
67 Massironi S, Rossi RE, Zilli A, Casazza G, Ciafardini C, Conte D. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival. Oncotarget. 2016;7:18978-18983. [PMID: 26959887 DOI: 10.18632/oncotarget.7902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
68 Starker LF, Prieto PA, Liles JS, Tran Cao HS, Grubbs EG, Lee JE, Perrier ND, Graham PH. Endocrine incidentalomas. Current Problems in Surgery 2016;53:219-46. [DOI: 10.1067/j.cpsurg.2016.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
69 Conemans EB, Brosens LA, Raicu-ionita GM, Pieterman CR, de Herder WW, Dekkers OM, Hermus AR, van der Horst-schrivers AN, Bisschop PH, Havekes B, Drent ML, Timmers HTM, Offerhaus GJ, Valk GD, Vriens MR. Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group. Pancreatology 2017;17:766-72. [DOI: 10.1016/j.pan.2017.07.196] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
70 Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) 2013;92:135-81. [PMID: 23645327 DOI: 10.1097/MD.0b013e3182954af1] [Cited by in Crossref: 111] [Cited by in F6Publishing: 54] [Article Influence: 13.9] [Reference Citation Analysis]
71 Falchetti A, Marini F, Luzi E, Giusti F, Cavalli L, Cavalli T, Brandi ML. Multiple endocrine neoplasia type 1 (MEN1): Not only inherited endocrine tumors. Genet Med 2009;11:825-35. [DOI: 10.1097/gim.0b013e3181be5c97] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
72 Fischer L, Mehrabi A, Büchler MW. [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy]. Chirurg 2011;82:583-90. [PMID: 21656305 DOI: 10.1007/s00104-011-2069-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
73 Amin S, Kim MK. Islet Cell Tumors of the Pancreas. Gastroenterol Clin North Am 2016;45:83-100. [PMID: 26895682 DOI: 10.1016/j.gtc.2015.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
74 Conemans EB, Nell S, Pieterman CR, de Herder WW, Dekkers OM, Hermus AR, van der Horst-schrivers AN, Bisschop PH, Havekes B, Drent ML, Vriens MR, Valk GD. Prognostic Factors for Survival of MEN1 Patients with Duodenopancreatic Tumors Metastatic to the Liver: Results from the Dmsg. Endocrine Practice 2017;23:641-8. [DOI: 10.4158/ep161639.or] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
75 Akerström G, Stålberg P. Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am 2009;89:1047-68. [PMID: 19836484 DOI: 10.1016/j.suc.2009.06.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
76 Lu YY, Zhu F, Jing DD, Wu XN, Lu LG, Zhou GQ, Wang XP. Multiple endocrine neoplasia type 1 with upper gastrointestinal hemorrhage and perforation: A case report and review. World J Gastroenterol 2013; 19(8): 1322-1326 [PMID: 23482249 DOI: 10.3748/wjg.v19.i8.1322] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Mauriello C, Napolitano S, Gambardella C, Candela G, De Vita F, Orditura M, Sciascia V, Tartaglia E, Lanza M, Santini L, Conzo G. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. Int J Surg 2015;21 Suppl 1:S10-4. [PMID: 26118605 DOI: 10.1016/j.ijsu.2015.04.089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
78 Wang BP, Tian WJ, Zhang J, Jiang CX, Qu HQ, Zhu M. Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1. J Int Med Res 2018;46:908-15. [PMID: 29239255 DOI: 10.1177/0300060517728653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Lewis MA, Thompson GB, Young WF Jr. Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1. World J Surg 2012;36:1375-81. [PMID: 22382771 DOI: 10.1007/s00268-012-1539-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
80 Rich TA, Perrier ND. Risk assessment and genetic counseling for multiple endocrine neoplasia type 1 (MEN1). Community Oncology 2008;5:502-14. [DOI: 10.1016/s1548-5315(11)70500-9] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]